Pharmacy substitution of Saxenda for a generic — for Switzerland
In many countries, the pharmacist may dispense an authorised generic of Saxenda (Liraglutide) instead of the branded version, often automatically or unless the prescriber explicitly objects. The substitution is regulated, the active ingredient stays the same, and the practical implications at 6 mg/mL mostly come down to price, manufacturer and tablet appearance.
Switzerland context
Substitution rules in Switzerland are set by Swissmedic (Swiss Agency for Therapeutic Products) and applied at dispensing. Swiss Apotheken/pharmacies are densely distributed with strict licensing; pharmacist counselling is integral to dispensing. Drogerien (drugstores) are unique to the Swiss system and sell category D and E medications without a pharmacist on staff. For Saxenda, this typically means the pharmacist may swap to an authorised generic of Liraglutide unless the prescriber has marked the prescription "do not substitute"; the clinical effect at 6 mg/mL stays the same and the price difference in CHF usually goes to the patient's benefit.
- Regulator
- Swissmedic (Swiss Agency for Therapeutic Products)
- Currency
- CHF
How substitution works
When the prescription specifies Saxenda, the pharmacist checks local rules: in some jurisdictions automatic substitution to the cheapest authorised generic is the default unless the doctor writes "do not substitute"; in others, the patient must explicitly accept or refuse the swap. The active ingredient Liraglutide stays the same, the strength stays the same (6 mg/mL), and the clinical effect is, on average, identical. Saxenda acts on the GLP-1 receptor in the central nervous system and gastrointestinal tract to reduce appetite, slow gastric emptying and increase satiety.
What you can ask
According to local pharmacy practice, patients can usually ask for the brand even when the generic is offered, accepting the price difference. They can also ask the pharmacist about the specific generic being dispensed — manufacturer, country of production and excipients — particularly relevant for users with known sensitivities. The pharmacist is the right person to clarify the substitution rules in your jurisdiction.
Frequently asked questions
Why is the pharmacy giving me a different brand of Saxenda? ▾
The pharmacy is dispensing an authorised generic of Liraglutide that is bioequivalent to Saxenda. Local substitution rules and the price difference are the usual reasons. The active substance and clinical effect at 6 mg/mL are the same.
Can I refuse the generic and keep getting Saxenda? ▾
Usually yes — most jurisdictions let patients pay the price difference and continue with the brand. The pharmacist confirms whether refusing substitution is allowed locally and what the cost gap is.
Pharmacy substitution of Saxenda for a generic in other countries
- the United StatesFDA (Food and Drug Administration)
- the United KingdomMHRA (Medicines and Healthcare products Regulatory Agency)
- SpainAEMPS (Agencia Española de Medicamentos y Productos Sanitarios)
- MexicoCOFEPRIS (Comisión Federal para la Protección contra Riesgos Sanitarios)
- ArgentinaANMAT (Administración Nacional de Medicamentos, Alimentos y Tecnología Médica)
- GermanyBfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)
- FranceANSM (Agence nationale de sécurité du médicament et des produits de santé)
- ItalyAIFA (Agenzia Italiana del Farmaco)
- BrazilANVISA (Agência Nacional de Vigilância Sanitária)
The information on this website is provided for reference and educational purposes only. It does not replace consultation with a qualified healthcare professional.